Filter posts

BIO Is Almost Here – What To Consider Before Entering New Therapeutic Areas

Over the past decade, the biopharmaceutical industry has witnessed a shift towards specialty care. From …

State of the Industry for Emerging Therapeutic Companies

Emerging therapeutic companies are at their strongest point in a decade. In our new report …

My Journey From BioGENEius to PhD Student

For as long as I can remember, I’ve known that research and biotechnology would be …

2012: A Critical Year for Biotechnology

In 2012, we must continue to look for ways to reduce risk; enhance reward; reduce …

Foundation Fighting Blindness Invests in Gene Therapy Research Projects

Recently, the Foundation Fighting Blindness announced an $8.25 million investment in six new gene therapy …

Scientists oppose European stem cell patent ban

 Great article about leading stem cell scientists stating that the ECJ Advocate’s recommendation to ban stem cell …

BIO submits comments on Australian Senate Patent Amendment

The Australian Senate has proposed the Patent Amendment (Human Genes and Biological Materials) Bill 2010 that …